Share on

Global Intrauterine Contraceptive Devices Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report - Segmented By Product Type and Region – Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1029
Pages: 182
Formats: report pdf report excel report power bi report ppt

Global Intrauterine Contraceptive Devices Market Size (2022 to 2027)

The global IUD market size is expected to value USD 2034 million by 2027 from USD 1610 million in 2022, growing at a CAGR of 4.78% during the forecast period.

The intrauterine contraceptive is a medical device used to insert into the uterus to avoid the chances of conceiving. The device is used as an emergency contraceptive post to the unwanted sex—two contraceptive devices like copper intrauterine contraceptive devices and hormonal intrauterine contraceptive devices. The medical device is a T-shaped device inserted into the uterus to prevent conception. IUCDs are generally a form of long-acting reversible contraceptives (LARC) assisting in birth control for an enlarged period. As per an article published by a patient, a web-based health information platform, Intrauterine contraceptives devices are cost-effective as 1 to 2 out of every 100 women will conceive after 5 years of using them. Couples or women who don't use IUCDs create and count may reach 80 out of 100 within a year. The demand for these intra-uterine contraceptive devices is significantly growing due to the research and development activities and innovative product launches.


The rise in awareness over the availability of these devices through campaigns and digital advertisements is majorly driving the growth of the IUD Market.

The Intrauterine Devices are small T-shaped devices placed in women’s uterus to prevent pregnancy. Hormone-based copper and hormone-based IUDs are two popular devices in the market. Some of the drivers that propel the Intrauterine Contraceptive Devices market are long-lasting, very good for preventing pregnancy, easy to use and maintain, and cost-effective. Initiative steps by the government in promoting the benefits with the use of IUDs greatly influence the demand of the market.

Additionally, the rise in the number of working-class women across the globe and advancements in the technology of IUDs, increasing the commonness of sexually transmitted diseases, and government funds are some of the other factors fueling the growth of the Global IUD Market.

The emergence of advanced technology and the launch of innovative products create growth opportunities for the market. Even in undeveloped countries, raising awareness of these devices is solely to fuel the market's demand. Also, ongoing research on developing new products is escalating the growth rate of the Intrauterine Contraceptive Devices market.


Factors that are hampering the market growth are inadequate importance during conception consultations, lack of proper knowledge over the use of the devices in rural areas, pelvic inflammatory infection, infertility issues, ectopic pregnancy, and limited access for conception. Factors like heavy bleeding, irregular bleeding, and cramps are the factors that are likely to sluggish the global intrauterine contraceptive devices market growth.

The shortage of skilled people in healthcare centers is a key challenging factor for the global intrauterine contraceptive devices market players.

Impact of COVID-19 on the global intrauterine contraceptive devices market:

The novel coronavirus has originated in Wuhan, China, and has spread to almost every corner of the world. The World Health Organization (WHO) declared an emergency public health issue in March 2020. The COVID 19 pandemic crisis has created a negative impact on contraceptives and the sexual health market. The primary disturbance is created due to the availability of contraceptives among the people—the decrease in the manufacturing and supply quantities of birth control pills worldwide. The incompetence of millions of men and women across the country to access contraceptives during the lockdown period is foreseen to significantly impact reproductive health indicators, including both maternal and infant mortality rates. The inadequate access to contraceptives over the best scenario case is to exhibit an extra 1.9 million unwanted pregnancies. Worldwide, 50% of pregnancies are unwanted. The intrauterine contraceptive devices market is expected to have significant growth in the coming years. 




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Product Type and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

Market Leaders Profiled

Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc, Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd, Okamato Industries, Inc, Pfizer.


This research report on the global intrauterine contraceptive devices market has been segmented and sub-segmented based on the product type and region.

Intrauterine Contraceptive Devices Market – By Product Type:

  • Hormonal
  • Copper

Based on product type, the Hormonal Intrauterine Contraceptive Devices segment is estimated to have the highest market share since hormonal Intrauterine Contraceptive Devices have fewer complications and risks non-hormonal Intrauterine Contraceptive Devices.

Intrauterine Contraceptive Devices Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America is expected to have the largest share in the global intrauterine contraceptive devices market value. The U.S. is one ruling with the largest shares of the market in this region. A growing number of young women are surging the demand of the market in this region.

Europe is expected to hold the second-largest share value of the IUD market. In this region, the factors driving this region are the rising number of sexually transmitted diseases and growing disposable income in urban areas.

Asia-Pacific is to hold the highest CAGR in the forecast period. India and China are significant countries contributing the highest shares to the market. Growing support from government and non-government organizations through investments in the healthcare center is leveraging the market's demand.


Some of the prominent companies leading the global intrauterine contraceptive devices market profiled in this report are Agile Therapeutics, Actavis PLC, ANI Pharmaceuticals, Inc., Bayer, Teva Pharmaceutical, Besins HealthCare, Brecuro Medical, Effik International, Eurogine, HLL Lifecare, HRA Pharma, Lupin Pharmaceuticals, Ltd., Okamato Industries, Inc., and Pfizer.


  • On February 14, 2020, Twirla, a contraceptive batch launched by Agile Therapeutics has been approved by U.S. FDA. In concern towards public safety, FDA has warned physicians do not to recommend this product for those who suffer from cardiovascular disease.
  • On September 19, 2016, Bayers's intrauterine device, familiarly known as Kyleena, was approved by the U.S. FDA. This device is very useful in preventing pregnancy and has fewer side effects.
  • On May 03, 2016, Allergan launched “LILETTA,” which helps women in the U.S. military. It is an initial step by the company to help military servicewomen, and this product strengthened the company's position in the global intrauterine contraceptive devices market.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample